Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19

Background. Acute kidney injury (AKI) is a common complication of COVID-19. Several etiologies have been identified, including pigment deposition likely associated with myopathic damage. Nevertheless, the relationship between longitudinal creatine-kinase trends and renal outcomes is uncertain. Aim....

Full description

Saved in:
Bibliographic Details
Main Authors: Juan M. Soto-Fajardo, Valeria J. Castillo-Avalos, Elisa Naomi Hernandez-Paredes, Airy Santillán-Cerón, Jorge E. Gaytan-Arocha, Olynka Vega-Vega, Norma Uribe, Ricardo Correa-Rotter, Juan C. Ramirez-Sandoval
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2022/8556793
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850210400370425856
author Juan M. Soto-Fajardo
Valeria J. Castillo-Avalos
Elisa Naomi Hernandez-Paredes
Airy Santillán-Cerón
Jorge E. Gaytan-Arocha
Olynka Vega-Vega
Norma Uribe
Ricardo Correa-Rotter
Juan C. Ramirez-Sandoval
author_facet Juan M. Soto-Fajardo
Valeria J. Castillo-Avalos
Elisa Naomi Hernandez-Paredes
Airy Santillán-Cerón
Jorge E. Gaytan-Arocha
Olynka Vega-Vega
Norma Uribe
Ricardo Correa-Rotter
Juan C. Ramirez-Sandoval
author_sort Juan M. Soto-Fajardo
collection DOAJ
description Background. Acute kidney injury (AKI) is a common complication of COVID-19. Several etiologies have been identified, including pigment deposition likely associated with myopathic damage. Nevertheless, the relationship between longitudinal creatine-kinase trends and renal outcomes is uncertain. Aim. To correlate longitudinal changes in serum creatine-kinase levels with hospital-acquired AKI (beyond 48 h of hospital admission) in severe COVID-19 patients. Methods. This is a retrospective cohort study, and creatine-kinase levels were assessed over time in 1551 hospitalized patients with normal renal function at the time of hospital admission. Results. In subjects who developed hospital-acquired AKI (n = 126, 8.1%), the serum creatine-kinase concentration before AKI onset was not different when compared to patients without AKI (slope of log creatine-kinase/day = −0.09 [95% CI −0.17 to +0.19] vs. +0.03 [95% CI −0.1 to +0.1]). After AKI diagnosis, serum creatine-kinase levels showed a significantly ascendent slope (slope of log creatine-kinase/day after AKI diagnosis = +0.14; 95% CI + 0.05 to +0.3). The AKI evolution was the main factor associated with the creatine-kinase trend. Subjects with persistent AKI (n = 40, 32%) had rising creatine-kinase levels during hospitalization (slope of log creatine-kinase/day = +0.30 95% CI + 0.19 to +0.51). A rising creatine-kinase trend (n = 114, 8%) was associated with a 1.89-fold higher risk of in-hospital death (95% CI 1.14 to 3.16). Nevertheless, this association disappeared after adjusting AKI evolution and LDH baseline levels. Conclusion. In severe COVID-19 patients, a slight increase in creatine-kinase levels was observed after AKI occurrence but not before. Our results show that, at least for the appearance of hospital-acquired AKI, the CK rise does not meet the temporality criterion of causality regarding the occurrence of AKI. Rising creatine-kinase trends were associated with a higher risk of mortality, but this association was modified by AKI evolution and inflammation. There is a limited efficiency for AKI prognosis in the serial follow-up of CK levels in severe COVID-19 patients with normal renal function.
format Article
id doaj-art-944b68f912854d20926bab75b8feb593
institution OA Journals
issn 2090-2158
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-944b68f912854d20926bab75b8feb5932025-08-20T02:09:47ZengWileyInternational Journal of Nephrology2090-21582022-01-01202210.1155/2022/8556793Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19Juan M. Soto-Fajardo0Valeria J. Castillo-Avalos1Elisa Naomi Hernandez-Paredes2Airy Santillán-Cerón3Jorge E. Gaytan-Arocha4Olynka Vega-Vega5Norma Uribe6Ricardo Correa-Rotter7Juan C. Ramirez-Sandoval8Department of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismDepartment of PathologyDepartment of Nephrology and Mineral MetabolismDepartment of Nephrology and Mineral MetabolismBackground. Acute kidney injury (AKI) is a common complication of COVID-19. Several etiologies have been identified, including pigment deposition likely associated with myopathic damage. Nevertheless, the relationship between longitudinal creatine-kinase trends and renal outcomes is uncertain. Aim. To correlate longitudinal changes in serum creatine-kinase levels with hospital-acquired AKI (beyond 48 h of hospital admission) in severe COVID-19 patients. Methods. This is a retrospective cohort study, and creatine-kinase levels were assessed over time in 1551 hospitalized patients with normal renal function at the time of hospital admission. Results. In subjects who developed hospital-acquired AKI (n = 126, 8.1%), the serum creatine-kinase concentration before AKI onset was not different when compared to patients without AKI (slope of log creatine-kinase/day = −0.09 [95% CI −0.17 to +0.19] vs. +0.03 [95% CI −0.1 to +0.1]). After AKI diagnosis, serum creatine-kinase levels showed a significantly ascendent slope (slope of log creatine-kinase/day after AKI diagnosis = +0.14; 95% CI + 0.05 to +0.3). The AKI evolution was the main factor associated with the creatine-kinase trend. Subjects with persistent AKI (n = 40, 32%) had rising creatine-kinase levels during hospitalization (slope of log creatine-kinase/day = +0.30 95% CI + 0.19 to +0.51). A rising creatine-kinase trend (n = 114, 8%) was associated with a 1.89-fold higher risk of in-hospital death (95% CI 1.14 to 3.16). Nevertheless, this association disappeared after adjusting AKI evolution and LDH baseline levels. Conclusion. In severe COVID-19 patients, a slight increase in creatine-kinase levels was observed after AKI occurrence but not before. Our results show that, at least for the appearance of hospital-acquired AKI, the CK rise does not meet the temporality criterion of causality regarding the occurrence of AKI. Rising creatine-kinase trends were associated with a higher risk of mortality, but this association was modified by AKI evolution and inflammation. There is a limited efficiency for AKI prognosis in the serial follow-up of CK levels in severe COVID-19 patients with normal renal function.http://dx.doi.org/10.1155/2022/8556793
spellingShingle Juan M. Soto-Fajardo
Valeria J. Castillo-Avalos
Elisa Naomi Hernandez-Paredes
Airy Santillán-Cerón
Jorge E. Gaytan-Arocha
Olynka Vega-Vega
Norma Uribe
Ricardo Correa-Rotter
Juan C. Ramirez-Sandoval
Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
International Journal of Nephrology
title Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
title_full Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
title_fullStr Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
title_full_unstemmed Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
title_short Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19
title_sort longitudinal changes of serum creatine kinase and acute kidney injury among patients with severe covid 19
url http://dx.doi.org/10.1155/2022/8556793
work_keys_str_mv AT juanmsotofajardo longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT valeriajcastilloavalos longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT elisanaomihernandezparedes longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT airysantillanceron longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT jorgeegaytanarocha longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT olynkavegavega longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT normauribe longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT ricardocorrearotter longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19
AT juancramirezsandoval longitudinalchangesofserumcreatinekinaseandacutekidneyinjuryamongpatientswithseverecovid19